TarekElrafeiDO

Oncology • Bronx, NY

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Associate Professor, Medicine, A Einstein College of Medicine of Yeshiva Univ

Join to view full profile

Dr. Elrafei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Elrafei's full profile

Already have an account?

Office
2330 Eastchester Road
Bronx, NY 10469
Phone+1 718-732-4000

Fax+1 718-828-1960

Summary

Dr. Tarek Elrafei is an oncologist in Bronx, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Jacobi and Montefiore Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 22 years. He specializes in breast cancer, cancer genetics/cancer risk assessment, and hematologic oncology and is experienced in hematologic oncology, hematology, and medical oncology.

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2000 - 2003
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1996 - 1999
Nova Southeastern University College of Osteopathic MedicineClass of 1995
Rutgers UniversityB.S., 1987 - 1991

Certifications & Licensure

NY State License 1998 - 2026
NJ State License 2000 - 2025
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
A systematic review of the literature on localized gastrointestinal tract amyloidosis: Presentation, management and outcomes.
Mariuxi Alexandra Viteri Malone, David Alfonso Alejos Castillo, Heitor Tavares Santos, Anahat Kaur, Tarek Elrafei
European Journal of Haematology. 2024-10-01
6 citations
Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism
Shunsuke Aoi, Amit Kakkar, Yosef Golowa, Michael Grushko, Christina M. Coyle
European Heart Journal. Case Reports. 2020-12-01
5 citations
Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database.
Shuai Wang, Apoorva Jayarangaiah, Mariuxi Alexandra Viteri Malone, Tarek N. Elrafei, Lewis Steinberg
Eclinicalmedicine. 2020-10-16

Journal Articles

Using a Patient Navigation Program to Overcome Health Care Disparities in Cancer Treatment in a Multicultural Setting
Tarek Elrafei, Maria Castaldi, Marianna Strakhan, Karenza Alexis, Louis Juden Reed, Bassam Shaker, Tina Stanise, Mariaelena Marquez, Richard J. Gralla, Supportive Care in Cancer, International MASCC/ISOO Symposium, 6/27/2013
A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients with oxaplatin-refra...
Allyson J. Ocean, Tanios S. Bekaii-Saab, Imran Chaudhary, Romae Palmer, Paul J. Christos, Alice Mercado, Erika O. Florendo, Veronica A. Rosales, Joseph T. Ruggiero, El..., Journal of Clinical Oncology, 1/1/2012
Dermatofibrosarcoma protuberans-derived fibrosarcoma: Response to escalated dose imatinib mesylate (IM) and second generation kinase-inhibitor nilotinib
T.N. Elrafei, G Chrysofakis, N Simmons, L.J. Reed, Journal of Clinical Oncology, 5/1/2011
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade((R))) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
Li T, Ho L, Piperdi B, Elrafei T, Camacho FJ, Rigas JR, Perez-Soler R, Gucalp R, Lung Cancer, 6/11/2009
Percutaneous kyphoplasty is an effective and safe treatment for painful vertebral compression fractures (VCF) in solid tumors
T.N. Elrafei, M. Hazza, N. Tindel, Journal of Clinical Oncology, 5/1/2009
Risks and benefits of phase I trials: 12 years experience from a single institution
U. Swami, M. H. Ghalib, I. Chaudhary, J. Y. Hou, S. Aparo, M. H. Einstein, G. L. Goldberg, T. N. Elrafei, S. Gajavelli, B. Cohen, L. Rajdev, A. Kaubisch, M. Haigentz, ..., Journal of Clinical Oncology
Join now to see all

Abstracts/Posters

Can patient navigation help overcome barriers to breast cancer treatment in patients with health care disparities?
Tarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Richard J. Gralla, Mariaelena Marquez, William Bodner, Louis Juden Reed, Marianna Strakhan, Karenza M. A..., San Antonio Breast Cancer Symposium, San Antonio, TX, 12/11/2013
Overcoming health care disparities in cancer treatment by instituting a patient navigation program
Tarek N. Elrafei, Maria Castaldi, Bassam Shaker, Tina Stanise, Mariaelena Marquez, William Bodner, Louis Juden Reed, Karenza M. Alexis, Marianna Strakhan, Richard J. G..., Journal of Clinical Oncology, 1/31/2013
Dermatofibrosarcoma protuberans: Preoperative therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response
M. Macapinlac, T. Elrafei, I. Cunningham, M. Horowitz, F. Paracha, R. Mbaoma, D. Jayabalan, S. Mani, Proceedings of American Society of Clinical Oncology, 6/1/2004
Is chemoradiation the treatment of choice for anal squamous cell carcinoma developing in HIV-positive patients with access to highly active antiretroviral therapy?
TG Allen-Mersh, A Hanna-Morris, SE Goldstone, JA Sparano, T Elrafei, M Bower, Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2004
Computer-assisted outreach by patient care navigators using laptop wireless communication
M. Castaldi, T. N. Elrafei, M. Broderick, H. Delany, Journal of Clinical Oncology
Join now to see all